Blackfynn is a privately-held life sciences company focused on the development of a data platform to enable integration and analysis of complex, multimodal research and clinical data to enable better therapeutics and clinical care for patients with neurologic disease. Firm has collaborations in place with the Children's Hospital of Philadelphia (CHOP), Mayo Clinic, Medtronic, University of Pennsylvania, the Epilepsy Study Consortium, DARPA and NIDA.
